8-K
Current Report
GYRE THERAPEUTICS, INC. Filed Acc 0001193125-18-047232
Material agreement · Executive or director change · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d531554d8k.htm…